ArticleCancer diagnosis & prognosis

Analysis of Early Progression in Advanced Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab.

Naoki Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.